HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon's African Pride buy offers A.P. Products international opportunities.

This article was originally published in The Rose Sheet

Executive Summary

REVLON A.P. PRODUCTS BUY GIVES FIRM 10% OF ETHNIC HAIR CARE MARKET with the addition of the African Pride, All-Ways Natural, Ginseng Miracle and 911 ethnic hair care brands, Revlon said June 8. Citing A.C. Nielsen data, Revlon noted the acquisition of New Rochelle, N.Y.-based A.P. Products will more than double Revlon's 4.4% market share in the ethnic hair care category and provide a natural mechanism for growth. The cosmetic company's current ethnic hair care portfolio includes the Creme of Nature, Realistic, Fabulaxer and Lotta Body brands. Revlon's choice to pursue the acquisition of the niche company reflects the strength of A.P. Products' "solid management" and position in the market. Terms of the acquisition of privately held A.P. were not disclosed.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel